Prevalence and predictors of Residual Sleepiness (RS) in Obstructive Sleep Apnea (OSA) Patients Treated with Positive Airway Pressure (PAP)
I. Bouloukaki (Heraklion (Crete), Greece), M. Fanaridis (Heraklion (Crete), Greece), G. Stathakis (Heraklion (Crete), Greece), C. Ermidou (Heraklion (Crete), Greece), V. Moniaki (Heraklion (Crete), Greece), E. Mavroudi (Heraklion (Crete), Greece), S. Schiza (Heraklion (Crete), Greece)
Source: International Congress 2022 – Clinical consequences and systemic effects of obstructive sleep apnoea
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Bouloukaki (Heraklion (Crete), Greece), M. Fanaridis (Heraklion (Crete), Greece), G. Stathakis (Heraklion (Crete), Greece), C. Ermidou (Heraklion (Crete), Greece), V. Moniaki (Heraklion (Crete), Greece), E. Mavroudi (Heraklion (Crete), Greece), S. Schiza (Heraklion (Crete), Greece). Prevalence and predictors of Residual Sleepiness (RS) in Obstructive Sleep Apnea (OSA) Patients Treated with Positive Airway Pressure (PAP). 4291
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|